Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Capital Expenditures (2016 - 2025)

Merit Medical Systems' Capital Expenditures history spans 15 years, with the latest figure at $24.5 million for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 88.35% year-over-year to $24.5 million; the TTM value through Dec 2025 reached $81.7 million, down 66.19%, while the annual FY2025 figure was $81.7 million, 132.54% up from the prior year.
  • Capital Expenditures for Q4 2025 was $24.5 million at Merit Medical Systems, up from $22.4 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $210.0 million in Q4 2024 and bottomed at -$18.9 million in Q4 2023.
  • The 5-year median for Capital Expenditures is $7.7 million (2021), against an average of $16.9 million.
  • The largest annual shift saw Capital Expenditures tumbled 3023.44% in 2021 before it soared 1212.05% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at -$17.1 million in 2021, then skyrocketed by 110.57% to $1.8 million in 2022, then plummeted by 1147.37% to -$18.9 million in 2023, then skyrocketed by 1212.05% to $210.0 million in 2024, then plummeted by 88.35% to $24.5 million in 2025.
  • Per Business Quant, the three most recent readings for MMSI's Capital Expenditures are $24.5 million (Q4 2025), $22.4 million (Q3 2025), and $31.0 million (Q2 2025).